GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
about
ERdj5 sensitizes neuroblastoma cells to endoplasmic reticulum stress-induced apoptosisCancer Microenvironment and Endoplasmic Reticulum Stress ResponseEndoplasmic reticulum chaperones and oxidoreductases: critical regulators of tumor cell survival and immunorecognitionThe Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer TherapeuticsMechanisms of disseminated cancer cell dormancy: an awakening fieldGermline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid CancerER chaperones in mammalian development and human diseasesCancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic PlatformCigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cellsExpression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus.Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survivalGRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.Protein Disulfide Isomerase Superfamily in Disease and the Regulation of ApoptosisElimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signalingThe endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survivalEndoplasmic reticulum stress and cancer.A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell deathER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK.The critical role of GRP78 in physiologic and pathologic stress.Repositioning of Verrucosidin, a purported inhibitor of chaperone protein GRP78, as an inhibitor of mitochondrial electron transport chain complex I.Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cellsThe small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stressThe autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinomaCross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimineInhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).HSP70s: From Tumor Transformation to Cancer Therapy.Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancerGRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphomaERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers.GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach.Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70.Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancerInterplay between unfolded protein response and autophagy promotes tumor drug resistance
P2860
Q24313289-347E82D1-D50C-447F-9A51-B6377ADC62CEQ26778533-F7242AB6-953F-4CB0-A0E5-85A20DE1F1DAQ26823628-8310D63D-6CD8-4C36-AAF1-ED82A47CF84FQ27026256-E8ECE608-1B99-4C67-8380-977B215D7773Q27027015-FBFD41F7-33A8-48F6-B9C9-733C725B03D2Q28115011-F146E0A7-9D31-4530-BD66-E6BAFBC1577DQ28300625-0B71E9DA-54F9-4FC5-9CF9-0C3EA4CB4243Q28545862-EE2C3CCF-043E-4DFE-8C3F-B72E06071474Q30845849-86085902-4557-483A-84A5-9FF08C2F5B17Q33323234-AB05EEB4-471B-4BC5-B2BD-286415DFAFB0Q33514439-48D191B2-7426-4297-A40C-FF669DBAD5FCQ33700800-48D10738-B727-4847-8837-2CFB10F67823Q33891952-55081DD2-4D4D-4348-BCD6-A08547C7AC95Q34153753-1E3A9A71-1FB0-4571-B27F-5176D57E178AQ34274152-DA777EF2-7E20-4BEF-AE0E-6375CA1E60E8Q34318367-435D98B5-FEB9-41AE-BE0D-186B0016AEDFQ34331960-3F8597DE-671A-48FB-9C2C-99761245D715Q34349252-A6533842-7882-42F0-847F-4051F4791B39Q34376123-4DAE2FF3-D2B5-436C-B3B2-01FBC980B35DQ34437578-2213DAEC-1B9F-4851-AA7D-1D9D95792AA0Q34460275-BE5F1601-1EF1-4690-A550-F35BB1FE660FQ34594217-60B0859E-5BEE-4645-B584-E8DC2570F4FEQ34766688-691DAE79-344D-4D28-AC74-A5B06CEAC544Q34988108-E39A4B27-E9B9-48CF-BD91-A4AC23C6AB9FQ35000683-5979D006-B888-4788-BAE3-E5882A0962F6Q35055351-CA464BA7-3E44-44BB-800B-A70F5F0430F1Q35080206-4A4E00FF-0E8B-4D00-BCC2-29D85EBD85A2Q35090829-456263FC-4E34-4BB7-9A68-E8C406593433Q35111066-4A7C86C4-A587-45CD-965A-74C291FE3C0EQ35181079-0968E351-E664-4A86-9898-1A67D6F23553Q35226519-FF3595F3-AF5E-43C7-AF73-870F112EC5ACQ35432445-C2682AE2-9E74-43AF-BC9C-6A01D725DA6AQ35475256-BBB77D87-5D57-45D7-8911-E2CD5DF63F46Q35579435-643689D9-93B2-4432-8BFE-861645457717Q35763853-0E42B5E2-2FB3-4BE3-9F63-EB66A7E2C078Q35864578-FB058323-416F-4A74-B0A0-5ED9D5A6DC1CQ35889115-D8B11F62-546A-4BC9-A54B-BBABD1A6A456Q35958280-E447FC8F-9A6A-4262-809A-1017957DF117Q36085418-3D3EF33E-1873-45F8-8CFD-A294EFA59A82Q36085556-10A5BBC2-1527-4060-B4F0-9B412032FA1E
P2860
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
@en
type
label
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
@en
prefLabel
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
@en
P2093
P1433
P1476
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
@en
P2093
Darcy Spicer
Eunjung Lee
Peter Nichols
Susan Groshen
P304
P356
10.1158/0008-5472.CAN-06-1660
P407
P577
2006-08-01T00:00:00Z